Literature DB >> 12965925

Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans.

Suzanne Brandt1, Peter Thorkildson, Thomas R Kozel.   

Abstract

Cryptococcus neoformans is surrounded by an antiphagocytic capsule whose primary constituent is glucuronoxylomannan (GXM). An epitope shared by GXM serotypes A, B, C, and D is immunodominant when mice are immunized with serotype A GXM. In contrast, an epitope shared only by serotypes A and D is immunodominant when mice are immunized with serotype D. Hybridomas secreting antibodies reactive with subdominant epitopes were identified through a positive-negative screening procedure in which antibody-secreting colonies were characterized by reactivity with both the immunizing polysaccharide and GXMs from each of the four major serotypes. In this manner, a monoclonal antibody (MAb) that was reactive with an epitope shared only by serotypes A and B was identified and designated F10F5. Such an epitope has not been described previously. Immunization of mice with de-O-acetylated serotype A GXM generated a hybridoma that secreted an antibody, designated F12D2, that was reactive with all four serotypes. Unlike previously described monoclonal and polyclonal panspecific antibodies, the reactivity of MAb F12D2 was not altered by de-O-acetylation of GXM. These results indicate that there are at least two panspecific GXM epitopes; one epitope is dependent on O acetylation for antibody reactivity, and the other is independent of O acetylation. This study identifies strategies for production of MAbs that are reactive with subdominant or cryptic GXM epitopes and provides new information regarding the antigenic makeup and the humoral immune response to GXM, an essential virulence factor that is a target for active and passive immunization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965925      PMCID: PMC193905          DOI: 10.1128/cdli.10.5.903-909.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  43 in total

1.  Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.

Authors:  T F Eckert; T R Kozel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

2.  Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans.

Authors:  T C MacGill; R S MacGill; A Casadevall; T R Kozel
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

3.  In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages.

Authors:  M Grinsell; L C Weinhold; J E Cutler; Y Han; T R Kozel
Journal:  J Infect Dis       Date:  2001-07-13       Impact factor: 5.226

4.  Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.

Authors:  Raymond M Duro; Dale Netski; Peter Thorkildson; Thomas R Kozel
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

Review 5.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae.

Authors:  O Lüderitz; A M Staub; O Westphal
Journal:  Bacteriol Rev       Date:  1966-03

6.  Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines.

Authors:  F Falugi; R Petracca; M Mariani; E Luzzi; S Mancianti; V Carinci; M L Melli; O Finco; A Wack; A Di Tommaso; M T De Magistris; P Costantino; G Del Giudice; S Abrignani; R Rappuoli; G Grandi
Journal:  Eur J Immunol       Date:  2001-12       Impact factor: 5.532

7.  Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.

Authors:  P Richmond; R Borrow; J Findlow; S Martin; C Thornton; K Cartwright; E Miller
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.

Authors:  Thomas R Kozel; Stuart M Levitz; Françoise Dromer; Marcellene A Gates; Peter Thorkildson; Guilhem Janbon
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

9.  Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.

Authors:  Dale Netski; Thomas R Kozel
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

10.  Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses.

Authors:  David S Berry; Freyja Lynn; Che-Hung Lee; Carl E Frasch; Margaret C Bash
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  12 in total

1.  Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule.

Authors:  Marcellene A Gates-Hollingsworth; Thomas R Kozel
Journal:  Mol Microbiol       Date:  2009-09-02       Impact factor: 3.501

2.  Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence.

Authors:  Michael J Davis; Alison J Eastman; Yafeng Qiu; Brian Gregorka; Thomas R Kozel; John J Osterholzer; Jeffrey L Curtis; Joel A Swanson; Michal A Olszewski
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

3.  A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.

Authors:  Mark Probert; Xin Zhou; Margaret Goodall; Simon A Johnston; Ewa Bielska; Elizabeth R Ballou; Robin C May
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

4.  Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Ann Percival; Sean Bauman; Joy Pelfrey; Graeme Meintjes; G Ntombomzi Williams; Nicky Longley; Thomas S Harrison; Thomas R Kozel
Journal:  Clin Infect Dis       Date:  2011-09-21       Impact factor: 9.079

5.  Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen.

Authors:  Ann Percival; Peter Thorkildson; Thomas R Kozel
Journal:  Clin Vaccine Immunol       Date:  2011-06-22

6.  Isolation and characterization of Cryptococcus neoformans spores reveal a critical role for capsule biosynthesis genes in spore biogenesis.

Authors:  Michael R Botts; Steven S Giles; Marcellene A Gates; Thomas R Kozel; Christina M Hull
Journal:  Eukaryot Cell       Date:  2009-01-30

7.  Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides.

Authors:  J Stacey Klutts; Tamara L Doering
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

8.  Elucidating the pathogenesis of spores from the human fungal pathogen Cryptococcus neoformans.

Authors:  Steven S Giles; Taylor R T Dagenais; Michael R Botts; Nancy P Keller; Christina M Hull
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

9.  mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.

Authors:  Thomas R Kozel; William J Murphy; Suzanne Brandt; Bruce R Blazar; Julie A Lovchik; Peter Thorkildson; Ann Percival; C Rick Lyons
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

10.  Human cytomegalovirus UL84 oligomerization and heterodimerization domains act as transdominant inhibitors of oriLyt-dependent DNA replication: evidence that IE2-UL84 and UL84-UL84 interactions are required for lytic DNA replication.

Authors:  Kelly S Colletti; Yiyang Xu; Sylvia A Cei; Margaret Tarrant; Gregory S Pari
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.